0 antall prosjekter

Dato fra ny til gammel

IS-TOPP-Toppfinans. av M.Curie-stipend

Characterisation of human exposure pathways to novel flame retardants

The project is part of the Marie Curie Initial Training Network "Indoor Contamination with Flame Retardants: Causes and Impacts - INFLAME", project no. 264600 within EUs 7th Framework Programme. The Norwegian Institute of Public Health (NIPH), Department of Exposure and Risk Assessment contribut...

Tildelt: kr 0,44 mill.

Prosjektperiode: 2012-2014

Sted: Oslo

IS-TOPP-Toppfinans. av M.Curie-stipend

Toppfinansiering - Nilsbo - Cornelis Borgesius

see attached DOW

Tildelt: kr 0,18 mill.

Prosjektperiode: 2012-2014

Sted: Trøndelag - Trööndelage

IS-BILAT-Mobilitet Norge-USA /Canada

Medication use in pregnancy with focus on attitudes, perception of risk and mental well-being

Depression is a common disorder during pregnancy and several studies have found maternal depression and anxiety to be risk factors for preterm delivery, low birth weight, operative delivery and admission to neonatal intensive care units. Studies show that pregnant women overestimate the risks, e...

Tildelt: kr 0,10 mill.

Prosjektperiode: 2012-2012

Sted: Oslo

GLOBHELS-Global helse

Development of biodegradable nanobeads as vaccines against tuberculosis.

Tuberculosis (TB), which is caused by infection with the bacterium Mycobacterium tuberculosis (M.tb), is a major burden globally and causes more than 1,3 million deaths every year. The only available vaccine against TB, the live vaccine Bacille Calmette Guerin (BCG), is however largely ineffectiv...

Tildelt: kr 3,7 mill.

Prosjektperiode: 2012-2017

Sted: Oslo

FRIMEDBIO-Fri prosj.st. med.,helse,biol

Transformation of grid signals to place signals in the mammalian space circuit

Det er kjent at posisjoneringssystemet i pattedyrhjernen inneholder flere funksjonelt spesialiserte celletyper, slik som plassceller i hippocampus og gitterceller, retningsceller og grenseceller i entorhinal cortex. Hvordan disse celletypene samhandler er imidlertid ikke godt forstått. Vi har tat...

Tildelt: kr 3,0 mill.

Prosjektperiode: 2012-2015

Sted: Trøndelag - Trööndelage

NAERINGSPH-Nærings-phd

Treatment of Non-Hodgkin Lymphoma with 177Lu-HH1/Betalutin

Tildelt: kr 1,9 mill.

Prosjektperiode: 2011-2014

Sted: Oslo

NEVRONOR-Nasjonal satsing på nevrovitenskap f

Støtte til konferansen Healthy Brain 2011

...

Tildelt: kr 0,10 mill.

Prosjektperiode: 2011-2011

Sted: Oslo

NOS-M2-Nordisk samarbeidsnemnd medisin

NRC-Conference 2011

...

Tildelt: kr 0,14 mill.

Prosjektperiode: 2011-2011

Sted: Vestland

NEVRONOR-Nasjonal satsing på nevrovitenskap f

Teknisk museum - utstilling

...

Tildelt: kr 0,25 mill.

Prosjektperiode: 2011-2011

Sted: Oslo

GLOBHELS-Global helse

Vaccine development in Orientia tsutsugamushi infection

Tildelt: kr 3,7 mill.

Prosjektperiode: 2010-2014

Sted: Oslo

GLOBHELS-Global helse

Advancing Rotavirus Vaccine Development (ARVAC) - BBIL Phase 3 Study

PATH?s Advancing Rotavirus Vaccine Development (ARVAC) project, the Indian Department of Biotechnology (DBT), and Bharat Biotech International, Ltd. (BBIL) conducted a Phase 3 efficacy study of BBILs 116E (ROTAVAC®) rotavirus vaccine, and an Expanded Program on Immunization (EPI) non?interference...

Tildelt: kr 23,3 mill.

Prosjektperiode: 2010-2017

Sted: Ukjent Fylke

GLOBHELS-Global helse

'Communicate to vaccinate': Building evidence for improving communication about childhood vaccinations in low- and middle-income countries

Background Effective provider-parent communication can improve childhood vaccination uptake and strengthen immunization services in low- and middle-income countries (LMICs). Building capacity to improve communication strategies has been neglected. Rigorou s research exists but is not readily foun...

Tildelt: kr 4,0 mill.

Prosjektperiode: 2010-2013

Sted: Oslo

GLOBHELS-Global helse

Novel vaccine candidates against meningococcal disease

Meningococcal disease is a leading cause of meningitis and septicaemia globally, most often striking small children and teenagers. Due to the lack of efficient vaccines, serogroup B meningococcal disease is currently emerging on a worldwide basis. The rat ional design of outer membrane protein-ba...

Tildelt: kr 4,0 mill.

Prosjektperiode: 2010-2013

Sted: Oslo

GLOBHELS-Global helse

Vaccibodies for SIV: a step towards an HIV vaccine for humans.

Aim: Vaccibodies are recombinant vaccine molecules that can target antigen presenting cells (APC) and enhance immune responses towards the delivered antigen. The primary objective of the present proposal is to develop Vaccibodies for simian immunodeficien cy virus (SIV) and to test whether they e...

Tildelt: kr 3,1 mill.

Prosjektperiode: 2010-2013

Sted: Oslo

GLOBHELS-Global helse

Molecular control of T cell memory

Tildelt: kr 5,5 mill.

Prosjektperiode: 2010-2014

Sted: Oslo

GLOBHELS-Global helse

Health systems strengthening within vaccination programmes: an ethnographic study (HEALVAC)

Within the global health field, donors, policymakers and researchers often emphasise the importance of “health system strengthening”. Health system strengthening has become a buzzword, but there is actually a great deal of ambiguity about what it means – to different people, at different levels o...

Tildelt: kr 3,6 mill.

Prosjektperiode: 2010-2016

Sted: Oslo

GLOBHELS-Global helse

Studies of humoral and cell-mediated protective immune markers during Mycobacterium tuberculosis infection in human population

Prosjektet har resultert i betydelige resultater i form av publikasjoner og presentasjoner på konferanser siden vår siste rapport i juli, 2014. Vi har nå gjennomført analyse og er ferdige med resultatet. Artikkelen "QuantiFERON-TB gold in-tube-test Conversions and reversions among tuberculosis pa...

Tildelt: kr 3,8 mill.

Prosjektperiode: 2010-2015

Sted: Oslo

GLOBHELS-Global helse

To what extent do user fees affect Hepatitis B vaccine coverage rates in China?

China has 93 million infected carriers of the HB virus; about 20 million with chronic infections. The main transmission of virus is vertical, within families, often from mother to child during childbirth. The probability for developing chronic infection i s 90% for infants (infected in first year...

Tildelt: kr 3,9 mill.

Prosjektperiode: 2010-2013

Sted: Oslo

GLOBHELS-Global helse

mVAC - Mobile innovations in recording child vaccination and health data in immunization registers

We will develop an innovative and mobile phone based solutions to create a fully digital system for recording immunizations at the individual level, which can be implemented in countries both with and without a public unique person ID structure/system. Pr imary health care workers will be equippe...

Tildelt: kr 5,4 mill.

Prosjektperiode: 2010-2014

Sted: Vestland

GLOBHELS-Global helse

Additional activities related to an ongoing project: Impact of the new vaccine MenAfriVac on carriage of serogroup A Neisseria meningitidis

Meningitis due to Neisseria meningitidis serogroup A represents an important public health problem in sub-Saharan Africa. New meningitis vaccines (against pneumococci, Hemophilus influenzae and serogroup C meningococci) manufactured by conjugating the pol ysaccharide to a carrier protein have bee...

Tildelt: kr 2,9 mill.

Prosjektperiode: 2010-2012

Sted: Oslo

GLOBHELS-Global helse

Development of a food-grade Lactobacillus-based oral vaccine delivery system

In low-income countries, efforts to increase immunization coverage are hampered by weak health systems. Furthermore, the unaffordable costs of some vaccines remain a major barrier for people to access vaccination services. To develop novel technologies fo r effective production and delivery of va...

Tildelt: kr 3,1 mill.

Prosjektperiode: 2010-2013

Sted: Akershus

GLOBHELS-Global helse

Biomarkers of mycobacterial infection and disease, and molecular characterization of mycobacteria from high TB-burden countries.

Tuberculosis (TB) is a major public health problem throughout the world. Currently, there are 8 million new cases and 2-3 million deaths annually from TB. More than 95% of all cases and 98% of all deaths occur in developing countries, where few resources are available to ensure proper treatment....

Tildelt: kr 3,0 mill.

Prosjektperiode: 2010-2013

Sted: Vestland

GLOBHELS-Global helse

Target cell recognition by natural killer cells

NK-celler utgjør omlag 5% av hvite blodlegemer. I tillegg til å drepe kreftceller kan NK-celler oppdage og drepe celler som er infisert med intracellulære mikroorganismer, slik som virus og visse typer bakterier og parasitter. Intracellulære infeksjoner kan være vanskelige å forebygge ved vaksi...

Tildelt: kr 3,9 mill.

Prosjektperiode: 2010-2016

Sted: Oslo

IS-NAD-Samarbeid med NORAD-land

Abdul, Shabbir Syed. Indisk spesialist 2009

...

Tildelt: kr 27 200

Prosjektperiode: 2009-2009

Sted: Troms - Romsa - Tromssa

GLOBHELS-Global helse

Development of a proposal on Norwegian engagement and collaborative projects in a phase III trial of oral rotavirus vaccine ORV 116E in Indi

See project descrioption

Tildelt: kr 0,50 mill.

Prosjektperiode: 2009-2010

Sted: Oslo

EVALPSYK-Evaluering - opptrappingsplan psykisk helse

Hovedrapport fra evalueringen av Opptrappingsplanen for psykisk helse

Mål og innhold for den sammenfattende rapporten 1.Rapporten er Forskningsrådets sluttrapport til Sosial- og helsedirektoratet (SHdir) fra evalueringsoppdraget. Sluttrapporten skal utgis av Forskningsrådet. 2.Rapporten skal bygge på: " Sentrale mål og forutsetninger for Opptrappingsplanen. "...

Tildelt: kr 1,1 mill.

Prosjektperiode: 2008-2009

Sted: Oslo

IS-STP-Statsstipendprogram, utlendinger

Suetterlin, Stefan, GB, statsstip 2008-09

...

Tildelt: kr 43 000

Prosjektperiode: 2008-2008

Sted: Oslo

MILGENHEL-Miljø, gener og helse

Forskningskoordinator på Program for Miljø, gener og helse

...

Tildelt: kr 0,62 mill.

Prosjektperiode: 2008-2010

Sted: Ukjent Fylke

YFF-Yngre, fremragende forskere

EXERCISE IN MEDICINE: BIO-EPIDEMIOLOGY OF FITNESS AND CARDIOVASCULAR DISEASE

The western Society epidemic of life-style-related disease is an impending threat to public health, as well as economy, and calls thus for effective, affordable treatment and prevention strategies. The project has the potential to identify the key cellula r and molecular mechanisms underlying the...

Tildelt: kr 10,0 mill.

Prosjektperiode: 2008-2011

Sted: Trøndelag - Trööndelage

DIV-INT-Annet internasjonalt samarbeid

HFSP kontingent

...

Tildelt: kr 47,6 mill.

Prosjektperiode: 2008-2020

Sted: Ukjent Fylke

1 2 3 4 5 6